Saliba Group - Physiology and biochemistry of the malaria parasite

The Saliba Group is investigating vitamin utilisation pathways in the red blood cell stage of the human malaria parasite Plasmodium falciparum. We are investigating these pathways as potential drug targets for new antimalarials.

Filter by keyword

Publications

Feeling hot in here: thermotolerance and drug sensitivity in malaria parasites

Event | Fri 28 February 2020
Audrey Odom John, Chief of the Division of Infectious Diseases at Children’s Hospital of Philadelphia. A physician-scientist, Dr. John’s NIH-funded research has focused on Plasmodium falciparum malaria parasites, with a particular interest in targeting parasite metabolism to identify novel targets for drug development

Piezo channels: tension, tethers and transduction

Event | Thu 26 July 2018

Mechanosensitive channels are fundamental molecular components of mechanosensory systems in all organisms.

Striving toward malaria eradication, by Christina Spry

Striving toward malaria eradication, by Christina Spry

Story | Sunday 16 August 2020
Striving toward malaria eradication: Development of a single drug to kill malaria parasites and the mosquitoes that transmit them.
parasite kaledascope

Challenging the host-parasite binary

Story | Monday 10 August 2020
Tunan (Nicole) Yu discusses Horwitz and Wilcox (2005) and taking a multi-faceted view towards parasites to manage disease risk.

Kevin Saliba

Story | Wednesday 11 June 2014
Lab research